8:22 AM
Leo Group India
| ||
| Merck Serono, Neopharma announce first pharmaceutical production agreement WAM - Emirates News Agency WAM Abu Dhabi, Dec 02th, 2012 (WAM)--Under the patronage of Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Higher Education and Scientific Research and Chairman of Neopharma, global pharmaceutical, Merck Serono, a division of Merck KGaA, ... See all stories on this topic » | ||
| Maker of generic Lipitor halts production of drug Worcester Telegram The contamination was the latest episode in a history of manufacturing lapses at Ranbaxy, which is a subsidiary of the Japanese pharmaceutical company Daiichi Sankyo. The company has been operating under a court-ordered consent decree since January ... See all stories on this topic » | ||
| The Need for Pharmaceutical Intervention Fund AllAfrica.com A research conducted on 90 drugs approved by US regulators between 1998 and 2000 reveals that the results of more than half of all clinical trials which demonstrate the safety and effectiveness of new drugs are not published within five years of the ... See all stories on this topic » | ||
| US co Cambrex appoints former Teva CEO Yanai vice-chairman Globes Former Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) CEO Shlomo Yanai has been appointed as non-executive vice-chairman by Cambrex Corp. (NYSE: CBM). Yanai was replaced by Dr. Jeremy Levin as Teva CEO in May 2012. See all stories on this topic » | ||
| New drug pricing set to change industry The Hindu The new National Pharmaceutical Pricing policy (NPPP), which is proposed to be implemented in the near future, could change the structure and dynamics of the Indian pharmaceutical industry. This is because the new policy proposes to move to a ... See all stories on this topic » | ||
| ||
| Industry calls for reform of lagging drug review system Global Times In China, access to innovative drugs generally lags four to eight years behind other countries, due to the prolonged review process as well as the low capacity of the review body, said a report released Friday by the R&D-based Pharmaceutical ... See all stories on this topic » | ||
| Big pharma: a sick industry Avaaz Daily Briefing Earlier this year, the medical establishment was rocked when pharmaceuticals giant GlaxoSmithKline reached a record-breaking $3bn settlement with US authorities for illegally promoting drugs to treat conditions they weren't designed to fix. So it didn ... See all stories on this topic » |
Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.
Delete this alert.
Create another alert.
Manage your alerts.
0 comments:
Post a Comment